Signet Healthcare Partners
23
24M
21
0.88
7
0.09
6
- Stages of investment
- Areas of investment
Summary
Signet Healthcare Partners is the famous VC, which was founded in 1998. The company was established in North America in United States. The leading representative office of defined VC is situated in the New York.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Fluxion Biosciences, Fluxion Biosciences, Sancilio and Company. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical, Life Science.
This Signet Healthcare Partners works on 2 percentage points less the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2014. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2014. The real fund results show that this VC is 33 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 deals per year.
The overall number of key employees were 4.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Signet Healthcare Partners, startups are often financed by Kodiak Venture Partners, Claremont Creek Ventures, Techno Venture Management. The meaningful sponsors for the fund in investment in the same round are TVM Capital, Kodiak Venture Partners, Claremont Creek Ventures. In the next rounds fund is usually obtained by Kodiak Venture Partners, TVM Capital, NRW.BANK.
Investments analytics
Analytics
- Total investments
- 23
- Lead investments
- 7
- Exits
- 6
- Rounds per year
- 0.88
- Follow on index
- 0.09
- Investments by industry
- Biotechnology (16)
- Pharmaceutical (14)
- Health Care (10)
- Manufacturing (8)
- Medical Device (4) Show 19 more
- Investments by region
-
- United States (16)
- Germany (2)
- Netherlands (1)
- Switzerland (1)
- Israel (1) Show 2 more
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Avg. valuation at time of investment
- 40M
- Group Appearance index
- 0.70
- Avg. company exit year
- 10
- Avg. multiplicator
- 4.81
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
DIREVO Industrial Biotechnology | 18 Oct 2007 | Biotechnology, Other Pharmaceuticals and Biotechnology, Industrial, Biomass Energy | Late Stage Venture | 16M | North Rhine-Westphalia, Cologne, Germany |
Paragonix Technologies | 07 Mar 2023 | Biotechnology, Health Care, Medical Device | Early Stage Venture | 24M | United States, Massachusetts, Cambridge |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.